He's a holistic obesity specialist who understands metabolic repair because he's lived this journey himself
Pani A, Gironi I, Di Vieste G, Mion E, Bertuzzi F, Pintaudi B (2020) From prediabetes to type 2 diabetes mellitus in women with polycystic ovary syndrome: lifestyle and pharmacological management
The following tables describe how many clicks can deliver how much dosage when using standard semaglutide pens: Semaglutide multi-dose pen (0.25/0.5 mg) Semaglutide multi-dose pen (1 mg) Semaglutide multi-dose pen (2 mg) Additionally, some compounding pharmacies offer compounded semaglutide with microdoses
Qsymia: A combination of phentermine and topiramate that reduces appetite and creates a feeling of fullness
In populations with added comorbidities, results are lower: TRIUMPH-2 (obesity + diabetes) showed 20.8%, TRIUMPH-3 (obesity + cardiovascular disease) showed 22.6%, and TRANSCEND-T2D-1 (diabetes-specific, 40 weeks) showed 16.8% all consistent with patterns seen across the GLP-1 drug class, where comorbidities reduce achievable weight loss
Benefits of Semaglutide Reduces food intake by lowering appetite Promotes satiety and fullness by slowing food digestion in the stomach Decreases body fat percentage through loss of visceral adipose tissue and belly fat Weight loss with decreased waist size (majority of patients lost at least 15% body weight) Improves cardiovascular risk profile including lowering cholesterol, inflammation, blood pressure and blood sugar Lowers HbA1c Enhances growth of B cells in the pancreas Prevents cognitive decline Side effects can include: Nausea, Vomiting, Abdominal Bloating, Lack of appetite, Diarrhea, and Constipation
